#hiv

A small clinical study suggests engineered immune cells may help some people with HIV maintain undetectable virus levels without ongoing medication, raising the prospect of longer-lasting control beyond daily antiretroir

Researchers report that blood measures of biological aging in certain white blood cells tracked cognitive and mood-related symptoms of depression more closely than physical symptoms, pointing toward a more specific bioma

The FDA has approved Merck’s Idvynso, a once-daily two-drug tablet for certain adults with HIV-1, adding a new oral option for people who are already virologically suppressed.

Researchers report an HIV vaccine design that steered immune responses toward a conserved region of the virus and produced broadly neutralizing antibodies in macaques.

Researchers at the Manchester Institute of Biotechnology say engineering biology could provide a cheaper and more sustainable way to manufacture the HIV drug Lenacapavir.

Researchers at Karolinska Institutet report an association between gut bacteria composition and the level of latent HIV in people receiving antiretroviral therapy, pointing to a possible new line of investigation in cure

A new study highlighted by Medical Xpress says HIV infections could rise 10% if U.S. CDC funding for local testing programs ends, underscoring how closely diagnosis, treatment, and prevention remain linked.